Amitriptyline is used to treat depression by increasing amounts of certain natural chemicals in the brain needed for mental balance. It belongs to a class of older antidepressants and may also be used for nerve pain, eating disorders, and migraine prevention.[2] Elavil is currently approved and in use across 37 indications[4].[1]
Elavil is one of 838 small molecule programs targeting Intervertebral Disc Displacement. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
FDA Applications
NDA/BLA/ANDA regulatory filings
Pipeline
Competition
386 competitors in Cystic Fibrosis
Elavil
Onglyza
Calciferol
Vibramycin
Actimmune
Proair HFA
Aztreonam Lysine
Advil
Tums
Amitiza
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Regulatory
Jan 1, 1982
ELAVIL
NDA NDA012704
Jan 1, 1982
ELAVIL
NDA NDA012703
Sources
Details